Novus Unfazed by Federal Cannabis Regulations: The Key? They Don’t Touch the Plant
Novus Cannabis MedPlan: An Innovative Health Insurance Carrier Integrating Cannabis with Traditional Health Plans
2024 Annual Report and Business Model
Financial Performance Highlights
- No Sales of Insider Shares: For 3 years
- Gross Revenue Increase: During this reporting period, Gross Revenue increased by 7.32% compared to December 31 in 2024 and 2023, respectively.
- Total Shareholder Equity: Increased by 5.3% as of December 31, 2024, compared to December 31, 2023.
- Net Revenue Increase: During this reporting period, EBITDA increased by 13.47% compared to December 31, 2024, and 2023.respectively
- Cash and Cash Equivalents: There was a 7.95% increase compared to the financial reporting periods ending December 31, 2024, and December 31, 2023, respectively.
- No Convertible Notes: No convertible notes were issued or outstanding
Shareholder Commitment:
- Insider Sales: No insider selling common stock for three years
- Leak Out Vendor Shares: Third-party vendors with treasury-issued stock must sell their shares gradually based on 15% of the average daily trading volume over the past 30 days.
- Debt Transparency: Frank Labrozzi, the CEO, is owed $163,425. He has no plans to exercise the call provision, and this debt instrument has no equity conversion provision.
Direct-to-Consumer Platform Launch:
- Introduced a Cannabis RX platform designed to:
- Provide direct sales to medical and recreational policyholders.
- Offer pre-negotiated discounts to enhance affordability.
- Build brand loyalty from cannabis consumers to cannabis brands
- Nationwide Network of licensed dispensaries across the U.S
- Combines cannabis and traditional healthcare benefits in a single plan
- Positioned as a disruptive solution in the medical and recreational cannabis industry
Market Expansion Efforts:
The platform targeted medical users, unregistered consumers from the illicit market, and recreational users.
- Created affordable wellness programs with customized insurance benefits.
- Partnering with dispensaries, cannabis brands, and insurance brokers nationwide to offer Novus MedPlan, which provides comprehensive coverage solutions for diverse needs.
- The untapped employer market captures market share by targeting companies adjusting HR policies on cannabis in the workplace.
- Advantages of cannabis that don't touch the plant
Unaffected by the Complications of Cannabis Compliance.
Novus is not affected by the SAFE Banking Act or rescheduling. As a non-plant-touching company, we face fewer legal and regulatory hurdles. Since federal cannabis laws do not directly affect us, we can operate across state and national borders without restrictions.
About Novus
Novus (NDEV) operates through its wholly-owned subsidiary, WCIG Insurance Services, Inc. The company provides health plans as a health insurance carrier in states with legal medical marijuana programs. Novus' business model is based on receiving insurance premiums and does not involve the cultivation, distribution, or sale of cannabis or cannabis-related products.the Benefit Monetization Ratio measures the annual total of monetized policies, offset by the operating cost ratio, a balance sheet line item derived from net asset value, and calculated as the price book value.
Integration Reimbursement of Cannabis Plans
- Employer-Centric Customization: The platform allows companies to tailor health benefits, including medical cannabis, to align with their HR policies and values.
- Positions Novus as a compliant, tax-advantaged solution for medical cannabis reimbursement with Health Savings Accounts and Health Reimbursement Account
- Allows cannabis policyholders to use pre-tax dollars for premiums, enhancing affordability and accessibility.
2024 Annual Report Review and Business Model in Summary
Financial Performance Highlights:
- No Sales of Insider Shares: For 3 years
- Gross Revenue Increase: During this reporting period, Gross Revenue increased by 7.32% compared to December 31 in both 2024 and 2023 respectively.
- Total Shareholder Equity: Increased by 5.3% as of December 31, 2024, compared to December 31, 2023.
- Net Revenue Increase: During this reporting period, EBITDA increased by 13.47% compared to December 31, 2024, and 2023.respectively
- Cash and Cash Equivalents: There was a 7.95% increase compared to the financial reporting periods ending December 31, 2024, and December 31, 2023, respectively.
- No Convertible Notes: No convertible notes issued or outstanding
Shareholder Commitment:
- Dilution: No common share dilution from June 15, 2021, to Q3 2024
- Insider Sales: No insider selling common stock for three years
- Leak Out Vendor Shares: Third-party vendors with treasury-issued stock must sell their shares gradually, based on 15% of the average daily trading volume over the past 30 days.
Direct-to-Consumer Platform Launch:
Introduced a Cannabis RX platform designed to:
- Provide direct sales to medical and recreational policyholders.
- Offer pre-negotiated discounts to enhance affordability.
- Build brand loyalty from cannabis consumers to cannabis brands
- Nationwide Network of licensed dispensaries across the U.S
- Combines cannabis and traditional healthcare benefits in a single plan
- Positioned as a disruptive solution in the medical and recreational cannabis industry
Market Expansion Efforts
The platform targeted medical users, unregistered consumers from the illicit market, and recreational users.
- Created affordable wellness programs with customized insurance benefits.
- Partnering with dispensaries, cannabis brands, and insurance brokers nationwide to offer Novus MedPlan, which provides comprehensive coverage solutions for diverse needs.
- The untapped employer market captures market share by targeting companies adjusting HR policies on cannabis in the workplace.
- Advantages of cannabis that don't touch the plant
Unaffected by the Complications of Cannabis Compliance.
Novus is not affected by the SAFE Banking Act or rescheduling. As a non-plant-touching company, we face fewer legal and regulatory hurdles. Since federal cannabis laws do not directly affect us, we can operate across state and national borders without restrictions.
About Novus
Novus (NDEV) operates through its wholly-owned subsidiary, WCIG Insurance Services, Inc. The company provides health plans as a health insurance carrier in states with legal medical marijuana programs. Novus' business model is based on receiving insurance premiums and does not involve the cultivation, distribution, or sale of cannabis or cannabis-related products.the Benefit Monetization Ratio measures the annual total of monetized policies, offset by the operating cost ratio, a balance sheet line item derived from net asset value, and calculated as the price book value.
Integration Reimbursement of Cannabis Plans
- Employer-Centric Customization: The platform allows companies to tailor health benefits, including medical cannabis, to align with their HR policies and values.
- Positions Novus as a compliant, tax-advantaged solution for medical cannabis reimbursement with Health Savings Accounts and Health Reimbursement Account
- Allows cannabis policyholders to use pre-tax dollars for premiums, enhancing affordability and accessibility.
Interested in Learning More About $NDEV?
This is not an offering of any kind; it's supplemental information. You are welcome to visit any of these links to learn about our company, but we recommend reviewing them with your financial advisor.
Disclaimer and Forward-Looking Statement Click Here
Questions? Contact us!
Get In Touch!
© 2025 Novus. All Rights Reserved. Privacy Policy. Disclaimer and Rule 17b.
Affiliate can only market to states where Novus MedPlan is licensed. Provider and Members can only sign up in states where Novus MedPlan is licensed. Any technical issues please contact [email protected] Copyrights © 2025 Novus Acquisition & Dev. All rights reserved.